EMEA-002559-PIP07-22
Submitted by Anonymous (not verified) on 30 May 2024 - 11:49
EMEA-002559-PIP07-22
Annual report highlights progress in science, medicines and health in 2023
Submitted by Anonymous (not verified) on 30 May 2024 - 10:53
Annual report highlights progress in science, medicines and health in 2023
Annexes - 2023 annual report of the European Medicines Agency
Submitted by Anonymous (not verified) on 30 May 2024 - 10:50
Annexes - 2023 annual report of the European Medicines Agency
Annex 10 - 2023 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Submitted by Anonymous (not verified) on 30 May 2024 - 10:49
Annex 10 - 2023 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
2023 annual report of the European Medicines Agency
Submitted by Anonymous (not verified) on 30 May 2024 - 10:48
2023 annual report of the European Medicines Agency
ICH M14 guideline on general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines Step 2b
Submitted by Anonymous (not verified) on 30 May 2024 - 8:13
ICH M14 guideline on general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines Step 2b
Referral: Procaine benzylpenicillin Article 82 European Commission final decision, 07/09/2023, 11/12/2023, 29/05/2024
Submitted by Anonymous (not verified) on 29 May 2024 - 15:14
Referral: Procaine benzylpenicillin Article 82 European Commission final decision, 07/09/2023, 11/12/2023, 29/05/2024
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
Submitted by Anonymous (not verified) on 29 May 2024 - 15:07
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
Human medicines European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira), voriconazole, Date of authorisation: 27/05/2015, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 29 May 2024 - 14:42
Human medicines European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira), voriconazole, Date of authorisation: 27/05/2015, Revision: 13, Status: Authorised
Annex XV - List of topiramate containing medicinal products in the European Union
Submitted by Anonymous (not verified) on 29 May 2024 - 13:48
Annex XV - List of topiramate containing medicinal products in the European Union